Filing Details
- Accession Number:
- 0000950170-24-091156
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-08-05 21:56:01
- Reporting Period:
- 2024-08-02
- Accepted Time:
- 2024-08-05 21:56:01
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 730272 | Repligen Corp | RGEN | Biological Products, (No Disgnostic Substances) (2836) | 042729386 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1733143 | Ralf Kuriyel | C/O Repligen Corporation 41 Seyon St., Bldg 1, Ste 100 Waltham MA 02453 | Senior Vp, R&D | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2024-08-02 | 6,973 | $159.36 | 12,288 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2024-08-02 | 175 | $86.10 | 12,463 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-08-02 | 175 | $158.85 | 12,288 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Acquisiton | 2024-08-02 | 175 | $0.00 | 175 | $86.10 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2030-02-27 | No | 4 | M | Direct |
Footnotes
- This option is fully vested and exercisable.Exhibit 24.1: Power of Attorney
Billionaire Hedge Funds
